{
    "eid": "2-s2.0-85146484866",
    "title": "Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Thitiporn Jaruthien",
        "Chonnipa Nantavithya",
        "Sakun Santisukwongchote",
        "Shanop Shuangshoti",
        "Piti Techavichit",
        "Darintr Sosothikul",
        "Jiraporn Amornfa",
        "Kanjana Shotelersuk"
    ],
    "citedby-count": 0,
    "ref-count": 31,
    "ref-list": [
        "International incidence of childhood cancer, 2001\u201310: a population-based registry study",
        "CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012\u20132016",
        "Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial",
        "Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)",
        "Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma",
        "Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial",
        "Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters",
        "Outcome and prognostic factors of radiation therapy for medulloblastoma",
        "Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma",
        "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary",
        "Primary Brain Tumor Research Productivity in Southeast Asia and Its Association With Socioeconomic Determinants and Burden of Disease",
        "Survival and Prognostic Factors in Pediatric Patients with Medulloblastoma in Southern Thailand",
        "Clinical Characteristic and Molecular Subgroups of Thai Pediatric Medulloblastomas at Queen Sirikit National Institute of Child Health",
        "Treatment of early childhood medulloblastoma by postoperative chemotherapy alone",
        "Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology",
        "Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time",
        "Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups",
        "Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort",
        "Factors affecting the prognosis of children with medulloblastoma: A single institution retrospective analysis of 40 cases",
        "Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis",
        "Medulloblastoma in the age of molecular subgroups: a review",
        "Molecular subgroups of medulloblastoma: the current consensus",
        "A 11-year experience of radiation therapy for medulloblastoma at King Chulalongkorn Memorial Hospital",
        "Children\u2019s Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma",
        "Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis",
        "An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)",
        "Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis",
        "Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children",
        "Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II",
        "Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT\u201991"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Rachadapisek Sompoch Endowment Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}